Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: ANIK stock price vs CHH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CHH's multiple
Needs CHH P/S.
Implied fair value · at ANIK's multiple
Needs ANIK P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ANIK FY 2025 (ended Dec 31, 2025) · CHH FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Anika Therapeutics, Inc. · implied price per share
Bear
-$0.46
Base
-$0.55
Bull
-$0.63
CHOICE HOTELS INTERNATIONAL INC /DE · implied price per share
Bear
$88.09
Base
$103.64
Bull
$119.18
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.07x
5.84x
Net debt / EBITDA
Leverage against operating earnings
30.49x
1.53x
Cash and equivalents
Liquid reserves on the balance sheet
$81.17M
$45.00M
Total debt
Interest-bearing obligations outstanding
$9.60M
$1.06B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ZIMMER BIOMET HOLDINGS, INC.
ANIK vs ZBH
STRYKER CORP
ANIK vs SYK
BECTON DICKINSON & CO
ANIK vs BDX
INTEGRA LIFESCIENCES HOLDINGS CORP
ANIK vs IART
MARRIOTT INTERNATIONAL INC /MD/
ANIK vs MAR
Hilton Worldwide Holdings Inc.
ANIK vs HLT
Hyatt Hotels Corp
ANIK vs H
HOST HOTELS & RESORTS, INC.
ANIK vs HST
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe ANIK can reverse its -5.9% revenue growth and improve margins enough to support earnings recovery, then the stock may be worth owning because the P/S-based implied price suggests 25.5% upside and the shares are within the historical band; otherwise, the weak profitability and 30.5x net debt/EBITDA argue for caution.
ANIK trades at $20.73 versus a P/S-implied value of $26.02, implying 25.5% upside on that framework. However, CHH comparison is not clean because ANIK and CHH operate with very different margin and leverage profiles, so the apparent discount is only partly supported by fundamentals.
Supporting Metrics
